🇺🇸 FDA
Patent

US 9974789

Substituted pyrazolopyrimidines as glucocerebrosidase activators

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 9974789 (Substituted pyrazolopyrimidines as glucocerebrosidase activators) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/519, A61K31/5377, A61P, A61P43/00